A new validated RP-HPLC method for the determination of Tinidazole and Roxithromycin in its bulk and pharmaceutical dosage forms

To develop and validate a novel reverse-phase high-performance liquid chromatography determination of Tinidazole and Roxithromycin in its Bulk and Pharmaceutical Dosage Forms. Examination of simultaneous determination is centered around the advancement of novel RP-HPLC systematic technique for the a...

Full description

Saved in:
Bibliographic Details
Main Authors: Akram, N. M. D., Gopal, N. Madana, Balakrishna, A., Reddy, N. Bakthavatchala, Zyryanov, Grigory V.
Format: Conference Proceeding
Language:English
Subjects:
Ambient temperature
Chromatography
Dosage
Flow velocity
High performance liquid chromatography
Ions
Pharmaceuticals
Shape optimization
Sodium acetate
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page
container_issue 1
container_start_page
container_title
container_volume 2280
creator Akram, N. M. D.
Gopal, N. Madana
Balakrishna, A.
Reddy, N. Bakthavatchala
Zyryanov, Grigory V.
description To develop and validate a novel reverse-phase high-performance liquid chromatography determination of Tinidazole and Roxithromycin in its Bulk and Pharmaceutical Dosage Forms. Examination of simultaneous determination is centered around the advancement of novel RP-HPLC systematic technique for the assurance of medication substance in strong oral dose shapes and their approval. The optimized chromatographic condition was established for the estimation of Tinidazole and Roxithromycin by using Agilent C18 (4.6 X 250mm, 5 µm) column, sodium acetate buffer (pH 3) and Methanol (30:70% v/v) as mobile phase at a flow rate of 1.0 ml/min sustain an ambient temperature. The total analysis time was 10 minutes and the retention of Tinidazole and Roxithromycin was found to be 2.352 and 5.941 min with an injection volume of 20 µl. The system suitability parameters proved for optimized chromatographic conditions for Tinidazole and Roxithromycin were within limits. The developed method was showing good resolution and separation factors.
doi_str_mv 10.1063/5.0018159
format conference_proceeding
fullrecord <record><control><sourceid>proquest_scita</sourceid><recordid>TN_cdi_proquest_journals_2455629954</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2455629954</sourcerecordid><originalsourceid>FETCH-LOGICAL-p288t-3072efc3d5fe62f01475cacee085bb4203b17670234085fe95e978e1042eb7ed3</originalsourceid><addsrcrecordid>eNp9kNFLwzAQxoMoOKcP_gcB34TOJG2a9nEMdcLAIRN8K2l7sZltU5N0Op_80-02wTfh4ODu933HfQhdUjKhJA5v-IQQmlCeHqER5ZwGIqbxMRoRkkYBi8KXU3Tm3JoQlgqRjND3FLfwgTey1qX0UOKnZTBfLma4AV-ZEitjsa8Al-DBNrqVXpsWG4VXuh0UX6YGLNtBZj61r6xptoVu8a68w3lfv-23XSVtIwvovS5kjUvj5CvsvBt3jk6UrB1c_PYxer67Xc3mweLx_mE2XQQdSxIfhEQwUEVYcgUxU4RGgheDI5CE53nESJhTEQvCwmiYKEg5pCIBSiIGuYAyHKOrg29nzXsPzmdr09t2OJmxiPOYpSmPBur6QLlC-_2vWWd1I-02oyTbJZzx7Dfh_-CNsX9g1pUq_AFnHn0S</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>conference_proceeding</recordtype><pqid>2455629954</pqid></control><display><type>conference_proceeding</type><title>A new validated RP-HPLC method for the determination of Tinidazole and Roxithromycin in its bulk and pharmaceutical dosage forms</title><source>American Institute of Physics:Jisc Collections:Transitional Journals Agreement 2021-23 (Reading list)</source><creator>Akram, N. M. D. ; Gopal, N. Madana ; Balakrishna, A. ; Reddy, N. Bakthavatchala ; Zyryanov, Grigory V.</creator><contributor>Zyryanov, Grigory V ; Santra, Sougata ; Sadieva, Leila K</contributor><creatorcontrib>Akram, N. M. D. ; Gopal, N. Madana ; Balakrishna, A. ; Reddy, N. Bakthavatchala ; Zyryanov, Grigory V. ; Zyryanov, Grigory V ; Santra, Sougata ; Sadieva, Leila K</creatorcontrib><description>To develop and validate a novel reverse-phase high-performance liquid chromatography determination of Tinidazole and Roxithromycin in its Bulk and Pharmaceutical Dosage Forms. Examination of simultaneous determination is centered around the advancement of novel RP-HPLC systematic technique for the assurance of medication substance in strong oral dose shapes and their approval. The optimized chromatographic condition was established for the estimation of Tinidazole and Roxithromycin by using Agilent C18 (4.6 X 250mm, 5 µm) column, sodium acetate buffer (pH 3) and Methanol (30:70% v/v) as mobile phase at a flow rate of 1.0 ml/min sustain an ambient temperature. The total analysis time was 10 minutes and the retention of Tinidazole and Roxithromycin was found to be 2.352 and 5.941 min with an injection volume of 20 µl. The system suitability parameters proved for optimized chromatographic conditions for Tinidazole and Roxithromycin were within limits. The developed method was showing good resolution and separation factors.</description><identifier>ISSN: 0094-243X</identifier><identifier>EISSN: 1551-7616</identifier><identifier>DOI: 10.1063/5.0018159</identifier><identifier>CODEN: APCPCS</identifier><language>eng</language><publisher>Melville: American Institute of Physics</publisher><subject>Ambient temperature ; Chromatography ; Dosage ; Flow velocity ; High performance liquid chromatography ; Ions ; Pharmaceuticals ; Shape optimization ; Sodium acetate</subject><ispartof>AIP conference proceedings, 2020, Vol.2280 (1)</ispartof><rights>Author(s)</rights><rights>2020 Author(s). Published by AIP Publishing.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>309,310,314,780,784,789,790,23930,23931,25140,27924,27925</link.rule.ids></links><search><contributor>Zyryanov, Grigory V</contributor><contributor>Santra, Sougata</contributor><contributor>Sadieva, Leila K</contributor><creatorcontrib>Akram, N. M. D.</creatorcontrib><creatorcontrib>Gopal, N. Madana</creatorcontrib><creatorcontrib>Balakrishna, A.</creatorcontrib><creatorcontrib>Reddy, N. Bakthavatchala</creatorcontrib><creatorcontrib>Zyryanov, Grigory V.</creatorcontrib><title>A new validated RP-HPLC method for the determination of Tinidazole and Roxithromycin in its bulk and pharmaceutical dosage forms</title><title>AIP conference proceedings</title><description>To develop and validate a novel reverse-phase high-performance liquid chromatography determination of Tinidazole and Roxithromycin in its Bulk and Pharmaceutical Dosage Forms. Examination of simultaneous determination is centered around the advancement of novel RP-HPLC systematic technique for the assurance of medication substance in strong oral dose shapes and their approval. The optimized chromatographic condition was established for the estimation of Tinidazole and Roxithromycin by using Agilent C18 (4.6 X 250mm, 5 µm) column, sodium acetate buffer (pH 3) and Methanol (30:70% v/v) as mobile phase at a flow rate of 1.0 ml/min sustain an ambient temperature. The total analysis time was 10 minutes and the retention of Tinidazole and Roxithromycin was found to be 2.352 and 5.941 min with an injection volume of 20 µl. The system suitability parameters proved for optimized chromatographic conditions for Tinidazole and Roxithromycin were within limits. The developed method was showing good resolution and separation factors.</description><subject>Ambient temperature</subject><subject>Chromatography</subject><subject>Dosage</subject><subject>Flow velocity</subject><subject>High performance liquid chromatography</subject><subject>Ions</subject><subject>Pharmaceuticals</subject><subject>Shape optimization</subject><subject>Sodium acetate</subject><issn>0094-243X</issn><issn>1551-7616</issn><fulltext>true</fulltext><rsrctype>conference_proceeding</rsrctype><creationdate>2020</creationdate><recordtype>conference_proceeding</recordtype><recordid>eNp9kNFLwzAQxoMoOKcP_gcB34TOJG2a9nEMdcLAIRN8K2l7sZltU5N0Op_80-02wTfh4ODu933HfQhdUjKhJA5v-IQQmlCeHqER5ZwGIqbxMRoRkkYBi8KXU3Tm3JoQlgqRjND3FLfwgTey1qX0UOKnZTBfLma4AV-ZEitjsa8Al-DBNrqVXpsWG4VXuh0UX6YGLNtBZj61r6xptoVu8a68w3lfv-23XSVtIwvovS5kjUvj5CvsvBt3jk6UrB1c_PYxer67Xc3mweLx_mE2XQQdSxIfhEQwUEVYcgUxU4RGgheDI5CE53nESJhTEQvCwmiYKEg5pCIBSiIGuYAyHKOrg29nzXsPzmdr09t2OJmxiPOYpSmPBur6QLlC-_2vWWd1I-02oyTbJZzx7Dfh_-CNsX9g1pUq_AFnHn0S</recordid><startdate>20201104</startdate><enddate>20201104</enddate><creator>Akram, N. M. D.</creator><creator>Gopal, N. Madana</creator><creator>Balakrishna, A.</creator><creator>Reddy, N. Bakthavatchala</creator><creator>Zyryanov, Grigory V.</creator><general>American Institute of Physics</general><scope>8FD</scope><scope>H8D</scope><scope>L7M</scope></search><sort><creationdate>20201104</creationdate><title>A new validated RP-HPLC method for the determination of Tinidazole and Roxithromycin in its bulk and pharmaceutical dosage forms</title><author>Akram, N. M. D. ; Gopal, N. Madana ; Balakrishna, A. ; Reddy, N. Bakthavatchala ; Zyryanov, Grigory V.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p288t-3072efc3d5fe62f01475cacee085bb4203b17670234085fe95e978e1042eb7ed3</frbrgroupid><rsrctype>conference_proceedings</rsrctype><prefilter>conference_proceedings</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Ambient temperature</topic><topic>Chromatography</topic><topic>Dosage</topic><topic>Flow velocity</topic><topic>High performance liquid chromatography</topic><topic>Ions</topic><topic>Pharmaceuticals</topic><topic>Shape optimization</topic><topic>Sodium acetate</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Akram, N. M. D.</creatorcontrib><creatorcontrib>Gopal, N. Madana</creatorcontrib><creatorcontrib>Balakrishna, A.</creatorcontrib><creatorcontrib>Reddy, N. Bakthavatchala</creatorcontrib><creatorcontrib>Zyryanov, Grigory V.</creatorcontrib><collection>Technology Research Database</collection><collection>Aerospace Database</collection><collection>Advanced Technologies Database with Aerospace</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Akram, N. M. D.</au><au>Gopal, N. Madana</au><au>Balakrishna, A.</au><au>Reddy, N. Bakthavatchala</au><au>Zyryanov, Grigory V.</au><au>Zyryanov, Grigory V</au><au>Santra, Sougata</au><au>Sadieva, Leila K</au><format>book</format><genre>proceeding</genre><ristype>CONF</ristype><atitle>A new validated RP-HPLC method for the determination of Tinidazole and Roxithromycin in its bulk and pharmaceutical dosage forms</atitle><btitle>AIP conference proceedings</btitle><date>2020-11-04</date><risdate>2020</risdate><volume>2280</volume><issue>1</issue><issn>0094-243X</issn><eissn>1551-7616</eissn><coden>APCPCS</coden><abstract>To develop and validate a novel reverse-phase high-performance liquid chromatography determination of Tinidazole and Roxithromycin in its Bulk and Pharmaceutical Dosage Forms. Examination of simultaneous determination is centered around the advancement of novel RP-HPLC systematic technique for the assurance of medication substance in strong oral dose shapes and their approval. The optimized chromatographic condition was established for the estimation of Tinidazole and Roxithromycin by using Agilent C18 (4.6 X 250mm, 5 µm) column, sodium acetate buffer (pH 3) and Methanol (30:70% v/v) as mobile phase at a flow rate of 1.0 ml/min sustain an ambient temperature. The total analysis time was 10 minutes and the retention of Tinidazole and Roxithromycin was found to be 2.352 and 5.941 min with an injection volume of 20 µl. The system suitability parameters proved for optimized chromatographic conditions for Tinidazole and Roxithromycin were within limits. The developed method was showing good resolution and separation factors.</abstract><cop>Melville</cop><pub>American Institute of Physics</pub><doi>10.1063/5.0018159</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0094-243X
ispartof AIP conference proceedings, 2020, Vol.2280 (1)
issn 0094-243X
1551-7616
language eng
recordid cdi_proquest_journals_2455629954
source American Institute of Physics:Jisc Collections:Transitional Journals Agreement 2021-23 (Reading list)
subjects Ambient temperature
Chromatography
Dosage
Flow velocity
High performance liquid chromatography
Ions
Pharmaceuticals
Shape optimization
Sodium acetate
title A new validated RP-HPLC method for the determination of Tinidazole and Roxithromycin in its bulk and pharmaceutical dosage forms
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-22T15%3A35%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_scita&rft_val_fmt=info:ofi/fmt:kev:mtx:book&rft.genre=proceeding&rft.atitle=A%20new%20validated%20RP-HPLC%20method%20for%20the%20determination%20of%20Tinidazole%20and%20Roxithromycin%20in%20its%20bulk%20and%20pharmaceutical%20dosage%20forms&rft.btitle=AIP%20conference%20proceedings&rft.au=Akram,%20N.%20M.%20D.&rft.date=2020-11-04&rft.volume=2280&rft.issue=1&rft.issn=0094-243X&rft.eissn=1551-7616&rft.coden=APCPCS&rft_id=info:doi/10.1063/5.0018159&rft_dat=%3Cproquest_scita%3E2455629954%3C/proquest_scita%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p288t-3072efc3d5fe62f01475cacee085bb4203b17670234085fe95e978e1042eb7ed3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2455629954&rft_id=info:pmid/&rfr_iscdi=true